# A Comparison of AlloMap Molecular Testing and Traditional Biopsy-based Surveillance for Heart Transplant Rejection Early Post-transplantation

> **NCT00962377** · NA · UNKNOWN · sponsor: **XDx** · enrollment: 40 (actual)

## Conditions studied

- Graft Rejection
- Heart Diseases

## Interventions

- **PROCEDURE:** Endomyocardial biopsy
- **PROCEDURE:** AlloMap Molecular Testing

## Key facts

- **NCT ID:** NCT00962377
- **Lead sponsor:** XDx
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2009-08
- **Primary completion:** 2011-12
- **Final completion:** 2011-12
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2010-12-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00962377

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00962377, "A Comparison of AlloMap Molecular Testing and Traditional Biopsy-based Surveillance for Heart Transplant Rejection Early Post-transplantation". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00962377. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*